Andrew D. Dickinson - 10 Nov 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Financial Officer
Signature: /s/ Amy Kim by Power of Attorney for Andrew D. Dickinson
Issuer symbol: GILD
Transactions as of: 10 Nov 2022
Net transactions value: -$70,293
Form type: 4
Filing time: 14 Nov 2022, 11:49:03 UTC
Previous filing: 12 Sep 2022
Next filing: 13 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+1,912	+2.8%		69,519	10 Nov 2022	Direct	F1
transaction	GILD	Common Stock	Tax liability	$70,293	-851	-1.2%	$82.60	68,668	10 Nov 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-1,912	-4%		45,513	10 Nov 2022	Common Stock	1,912		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.